Lilly to acquire biopharma company DICE Therapeutics in $2.4bn deal

Pallavi Madhiraju- June 20, 2023 0

Eli Lilly and Company (Lilly) has agreed to acquire US-based biopharmaceutical company DICE Therapeutics, listed on the Nasdaq, in an all-cash deal worth $2.4 billion. ... Read More

Lupin, Enzene Biosciences to launch cancer drug Cetuximab biosimilar in India

Pallavi Madhiraju- May 31, 2023 0

Lupin, an Indian pharmaceutical company, has announced a strategic collaboration with Enzene Biosciences, a subsidiary of Alkem Laboratories, to introduce Cetuximab in India. Cetuximab is ... Read More

Lilly to sell hypoglycemia drug BAQSIMI to Amphastar Pharmaceuticals

Pallavi Madhiraju- April 24, 2023 0

Eli Lilly and Company (Lilly) has agreed to sell its severe hypoglycemia drug BAQSIMI to Amphastar Pharmaceuticals in a deal potentially worth up to $1.07 ... Read More

Roche, Lilly team up to develop EAPP blood test for Alzheimer’s disease

Pallavi Madhiraju- March 22, 2023 0

Roche is teaming up with Eli Lilly and Company (Lilly) to support the development of its Elecsys Amyloid Plasma Panel (EAPP) blood test which has ... Read More

Lilly gets Jaypirca FDA approval for mantle cell lymphoma

Raghuram Kadari- January 30, 2023 0

Loxo@Lilly, the oncology division of Eli Lilly and Company (Lilly), has secured the accelerated approval of the US Food and Drug Administration (FDA) for Jaypirca ... Read More

Lilly to invest further $450m to expand capacity at Research Triangle Park

Raghuram Kadari- January 26, 2023 0

Eli Lilly and Company (Lilly) is planning to invest an additional $450 million to increase the company’s production capacity at its Research Triangle Park facility ... Read More

Eagle Pharmaceuticals gets Pemfexy FDA approval for NSCLC

Raghuram Kadari- December 28, 2022 0

Eagle Pharmaceuticals has secured an additional indication for Pemfexy (pemetrexed injection) in the US, marking the fifth indication for the intravenous medication. Pemfexy in combination ... Read More

Lilly to acquire gene therapy firm Akouos to discover hearing loss treatments

BNT Reporter- October 19, 2022 0

Lilly acquisition of Akouos : American pharmaceutical giant Eli Lilly and Company (Lilly) has agreed to acquire precision genetic medicine company Akouos in a cash ... Read More

Lilly gets FDA fast track designation for tirzepatide in obesity

Pallavi Madhiraju- October 8, 2022 0

Eli Lilly and Company (Lilly) has been granted fast track designation for tirzepatide from the US Food and Drug Administration (FDA) for the treatment of ... Read More

Innovent Biologics, Sanofi to expedite development of cancer drugs in China

pallavi123- August 6, 2022 0

Chinese biopharma company Innovent Biologics and French pharma giant Sanofi have entered into a partnership that aims to bring innovative drugs to patients in China ... Read More